Form 4: Clover Health Director Garipalli's RSU Vesting & Tax Sale

Clover Health Investments Director and 10% owner Vivek Garipalli reported the vesting of restricted stock units and subsequent share withholding for tax obligations.

Summary

• Vivek Garipalli, a Director and 10% owner of Clover Health Investments, Corp., reported transactions on January 7, 2026, related to the vesting of restricted stock units (RSUs).
• The final 20% of his RSUs, originally granted on January 7, 2021, vested on this date.
• This vesting resulted in the delivery of 1,686,750 shares of Class B Common Stock to Mr. Garipalli.
• Concurrently, 1,655,949 shares of Class B Common Stock were automatically converted into Class A Common Stock and withheld by the Issuer to cover Mr. Garipalli's tax obligations in connection with the vesting event, at a price of $2.59 per share.
• Following these transactions, Mr. Garipalli directly beneficially owns 1,856,247 shares of Class A Common Stock and 8,591,093 shares of Class B Common Stock.
• Indirectly, through NJ Healthcare Investments, LLC, his beneficial ownership of Class B Common Stock decreased from 75,694,143 shares to 72,084,543 shares.
• Through Ceasar Clover, LLC, he indirectly beneficially owns 11,500,000 shares of Class B Common Stock, which remains unchanged.

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-scheduled compensation event (RSU vesting) for a key insider. While there's a sale for tax purposes and a reduction in indirect ownership, the core event is expected and reflects ongoing executive compensation. The insider retains substantial ownership, which is generally positive.

Positives

• The scheduled vesting of restricted stock units represents a planned compensation event for a key insider, aligning management's interests with long-term company performance.
• The insider retains substantial direct and indirect ownership in Clover Health, demonstrating continued commitment to the company.

Negatives

• A significant portion of the vested shares (1,655,949 Class A Common Stock) was withheld by the Issuer to cover tax obligations, reducing the net direct beneficial ownership from the gross vested amount.
• Indirect beneficial ownership through NJ Healthcare Investments, LLC decreased by 3,609,600 shares of Class B Common Stock.

Future Outlook

NA

Industry Context

This Form 4 filing details an insider transaction, specifically the vesting of restricted stock units and subsequent tax-related share withholding for a director and significant owner of Clover Health Investments. Such transactions are routine for executive compensation and do not inherently reflect broader industry trends or competitive positioning.

Related Party Transactions

• Vivek Garipalli serves as the sole manager of NJ Healthcare Investments, LLC and Caesar Clover, LLC, which hold significant indirect beneficial ownership of Clover Health's Class B Common Stock. This structure represents a related party relationship for ownership purposes.

Stakeholder Impact

• Shareholders: The filing indicates a routine compensation event for a key insider. The sale of shares for tax purposes is common and not necessarily indicative of a lack of confidence. The insider retains significant ownership, which can be viewed positively as alignment of interests.
• Employees: No direct impact on employees is indicated.
• Customers: No direct impact on customers is indicated.
• Suppliers: No direct impact on suppliers is indicated.
• Creditors: No direct impact on creditors is indicated.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled RSU vesting and subsequent tax-related share withholding for a director. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment thesis. The insider retains substantial ownership, which is a positive for alignment, but the transaction itself is an expected compensation event. Therefore, a 'hold' recommendation is appropriate as there's no new information to drive a 'buy' or 'sell' decision based solely on this filing.

Keywords

Clover Health Investments, CLOV, Vivek Garipalli, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Stock Ownership, Tax Withholding, Class A Common Stock, Class B Common Stock, Director, 10% Owner